Body mass index and cancer mortality in patients with incident type 2 diabetes: A population‐based study of adults in England
Aims We evaluated the relationship between body mass index (BMI) and cancer mortality in incident type 2 diabetes. Methods We used the Clinical Practice Research Datalink GOLD (1998‐2015), linked with the Office of National Statistics mortalities, and derived an incident type 2 diabetes cohort (N = ...
Saved in:
Published in | Diabetes, obesity & metabolism Vol. 24; no. 4; pp. 620 - 630 |
---|---|
Main Authors | , , , , , , |
Format | Journal Article |
Language | English |
Published |
Oxford, UK
Blackwell Publishing Ltd
01.04.2022
Wiley Subscription Services, Inc |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | Aims
We evaluated the relationship between body mass index (BMI) and cancer mortality in incident type 2 diabetes.
Methods
We used the Clinical Practice Research Datalink GOLD (1998‐2015), linked with the Office of National Statistics mortalities, and derived an incident type 2 diabetes cohort (N = 176 886; aged 30‐85 years). We determined BMI ±12 months diabetes diagnosis. The primary outcome was cancer mortality, categorized into deaths from obesity‐related cancers (ORCs) and non‐ORCs. Secondary outcomes were site‐specific cancer mortality and main causes of deaths [cancer, cardiovascular disease (CVD), non‐cancer non‐CVD]. We developed gender‐specific Cox models and expressed risk as hazard ratios and 95% confidence intervals, stratified by smoking status.
Results
With 886 850 person‐years follow‐up, 7593 cancer deaths occurred. Among women who never smoked, there were positive associations between BMI and deaths from endometrial (hazard ratios per 5 kg/m2: 1.43; 95% confidence interval 1.26‐1.61). Among men, associations between BMI and ORC mortality were inverse but attenuated towards null among never smokers and excluding deaths in the first 2 years. In men, the proportion of CVD deaths increased from 36.8% in BMI category 22.5 to 24.9 kg/m2 to 43.6% in BMI category ≥40 kg/m2 (p < .001).
Conclusions
We found some relationships between BMI and cancer mortality in patients with type 2 diabetes, but interpretations need to account for smoking status, reverse causality and deaths from CVD. |
---|---|
AbstractList | AimsWe evaluated the relationship between body mass index (BMI) and cancer mortality in incident type 2 diabetes.MethodsWe used the Clinical Practice Research Datalink GOLD (1998‐2015), linked with the Office of National Statistics mortalities, and derived an incident type 2 diabetes cohort (N = 176 886; aged 30‐85 years). We determined BMI ±12 months diabetes diagnosis. The primary outcome was cancer mortality, categorized into deaths from obesity‐related cancers (ORCs) and non‐ORCs. Secondary outcomes were site‐specific cancer mortality and main causes of deaths [cancer, cardiovascular disease (CVD), non‐cancer non‐CVD]. We developed gender‐specific Cox models and expressed risk as hazard ratios and 95% confidence intervals, stratified by smoking status.ResultsWith 886 850 person‐years follow‐up, 7593 cancer deaths occurred. Among women who never smoked, there were positive associations between BMI and deaths from endometrial (hazard ratios per 5 kg/m2: 1.43; 95% confidence interval 1.26‐1.61). Among men, associations between BMI and ORC mortality were inverse but attenuated towards null among never smokers and excluding deaths in the first 2 years. In men, the proportion of CVD deaths increased from 36.8% in BMI category 22.5 to 24.9 kg/m2 to 43.6% in BMI category ≥40 kg/m2 (p < .001).ConclusionsWe found some relationships between BMI and cancer mortality in patients with type 2 diabetes, but interpretations need to account for smoking status, reverse causality and deaths from CVD. Aims We evaluated the relationship between body mass index (BMI) and cancer mortality in incident type 2 diabetes. Methods We used the Clinical Practice Research Datalink GOLD (1998‐2015), linked with the Office of National Statistics mortalities, and derived an incident type 2 diabetes cohort (N = 176 886; aged 30‐85 years). We determined BMI ±12 months diabetes diagnosis. The primary outcome was cancer mortality, categorized into deaths from obesity‐related cancers (ORCs) and non‐ORCs. Secondary outcomes were site‐specific cancer mortality and main causes of deaths [cancer, cardiovascular disease (CVD), non‐cancer non‐CVD]. We developed gender‐specific Cox models and expressed risk as hazard ratios and 95% confidence intervals, stratified by smoking status. Results With 886 850 person‐years follow‐up, 7593 cancer deaths occurred. Among women who never smoked, there were positive associations between BMI and deaths from endometrial (hazard ratios per 5 kg/m2: 1.43; 95% confidence interval 1.26‐1.61). Among men, associations between BMI and ORC mortality were inverse but attenuated towards null among never smokers and excluding deaths in the first 2 years. In men, the proportion of CVD deaths increased from 36.8% in BMI category 22.5 to 24.9 kg/m2 to 43.6% in BMI category ≥40 kg/m2 (p < .001). Conclusions We found some relationships between BMI and cancer mortality in patients with type 2 diabetes, but interpretations need to account for smoking status, reverse causality and deaths from CVD. Abstract Aims We evaluated the relationship between body mass index (BMI) and cancer mortality in incident type 2 diabetes. Methods We used the Clinical Practice Research Datalink GOLD (1998‐2015), linked with the Office of National Statistics mortalities, and derived an incident type 2 diabetes cohort (N = 176 886; aged 30‐85 years). We determined BMI ±12 months diabetes diagnosis. The primary outcome was cancer mortality, categorized into deaths from obesity‐related cancers (ORCs) and non‐ORCs. Secondary outcomes were site‐specific cancer mortality and main causes of deaths [cancer, cardiovascular disease (CVD), non‐cancer non‐CVD]. We developed gender‐specific Cox models and expressed risk as hazard ratios and 95% confidence intervals, stratified by smoking status. Results With 886 850 person‐years follow‐up, 7593 cancer deaths occurred. Among women who never smoked, there were positive associations between BMI and deaths from endometrial (hazard ratios per 5 kg/m 2 : 1.43; 95% confidence interval 1.26‐1.61). Among men, associations between BMI and ORC mortality were inverse but attenuated towards null among never smokers and excluding deaths in the first 2 years. In men, the proportion of CVD deaths increased from 36.8% in BMI category 22.5 to 24.9 kg/m 2 to 43.6% in BMI category ≥40 kg/m 2 ( p < .001). Conclusions We found some relationships between BMI and cancer mortality in patients with type 2 diabetes, but interpretations need to account for smoking status, reverse causality and deaths from CVD. We evaluated the relationship between body mass index (BMI) and cancer mortality in incident type 2 diabetes. We used the Clinical Practice Research Datalink GOLD (1998-2015), linked with the Office of National Statistics mortalities, and derived an incident type 2 diabetes cohort (N = 176 886; aged 30-85 years). We determined BMI ±12 months diabetes diagnosis. The primary outcome was cancer mortality, categorized into deaths from obesity-related cancers (ORCs) and non-ORCs. Secondary outcomes were site-specific cancer mortality and main causes of deaths [cancer, cardiovascular disease (CVD), non-cancer non-CVD]. We developed gender-specific Cox models and expressed risk as hazard ratios and 95% confidence intervals, stratified by smoking status. With 886 850 person-years follow-up, 7593 cancer deaths occurred. Among women who never smoked, there were positive associations between BMI and deaths from endometrial (hazard ratios per 5 kg/m : 1.43; 95% confidence interval 1.26-1.61). Among men, associations between BMI and ORC mortality were inverse but attenuated towards null among never smokers and excluding deaths in the first 2 years. In men, the proportion of CVD deaths increased from 36.8% in BMI category 22.5 to 24.9 kg/m to 43.6% in BMI category ≥40 kg/m (p < .001). We found some relationships between BMI and cancer mortality in patients with type 2 diabetes, but interpretations need to account for smoking status, reverse causality and deaths from CVD. |
Author | Alam, Nasra N. Sperrin, Matthew Buchan, Iain Renehan, Andrew G. Rutter, Martin K. Ashcroft, Darren M. Wright, Alison K. |
Author_xml | – sequence: 1 givenname: Nasra N. orcidid: 0000-0003-4362-9928 surname: Alam fullname: Alam, Nasra N. email: nalam@sent.com organization: University of Manchester – sequence: 2 givenname: Alison K. orcidid: 0000-0002-8418-8332 surname: Wright fullname: Wright, Alison K. organization: University of Manchester – sequence: 3 givenname: Martin K. surname: Rutter fullname: Rutter, Martin K. organization: Manchester Academic Health Sciences Centre – sequence: 4 givenname: Iain surname: Buchan fullname: Buchan, Iain organization: University of Manchester – sequence: 5 givenname: Darren M. surname: Ashcroft fullname: Ashcroft, Darren M. organization: University of Manchester, Manchester Academic Health Sciences Centre – sequence: 6 givenname: Matthew surname: Sperrin fullname: Sperrin, Matthew organization: University of Manchester – sequence: 7 givenname: Andrew G. surname: Renehan fullname: Renehan, Andrew G. organization: University of Manchester |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/34866302$$D View this record in MEDLINE/PubMed |
BookMark | eNp1kctO3jAQhS1ExX3BCyBL3ZRFwJfEcbrj1osEYtOuI18mrVFih9gRzap9BJ6RJ6l_ftoFEt6MPfPpnJHPLtr0wQNCh5Sc0HxObRhOaClouYF2cuUF5UxsPt9ZIRvCttFujHeEkJLLegtt81IKwQnbQb_Pg13woGLEzlv4hZW32ChvYMJDmJLqXVryCI8qOfAp4geXfuaGcTY_cVpGwAxbpzQkiB_xGR7DOPeZDv7pz6NWESyOac4uocPKzn1aWeEr_6PPXvvoXaf6CAcvdQ99_3T17eJLcX37-evF2XVhuJRlUVEpoKm57nSttKw4q3Rlm66paFNxZRvGgUtWC93wkpkKqKolEdpQQY1oCN9DH9a64xTuZ4ipHVw00OcdIMyxZYLUnOYf4hl9_wq9C_Pk83aZ4jVjFWEr6nhNmSnEOEHXjpMb1LS0lLSrVNqcSvucSmaPXhRnPYD9T_6LIQOna-DB9bC8rdRe3t6sJf8CSj6YIA |
CitedBy_id | crossref_primary_10_1097_MD_0000000000030136 crossref_primary_10_3389_fonc_2022_975201 |
Cites_doi | 10.1371/journal.pmed.1002081 10.1016/j.jclinepi.2019.02.016 10.1007/s00125-018-4664-5 10.1001/jama.2012.9282 10.1136/bmj.39582.447998.BE 10.1136/bmjdrc-2016-000369 10.7326/0003-4819-147-3-200708070-00167 10.1093/ije/dyz005 10.1016/S2213-8587(20)30431-9 10.1210/jc.2013-3210 10.1016/j.atherosclerosis.2012.09.004 10.1056/NEJMsr1606602 10.1186/1475-2840-7-32 10.2337/dc12-0002 10.1111/j.1464-5491.2009.02917.x 10.1002/acr.22882 10.1186/1471-2288-13-13 10.2337/dc16-1616 10.1016/S0140-6736(08)60269-X 10.1001/jamanetworkopen.2021.1793 10.1016/j.jclinepi.2009.08.028 10.1038/nrc3967 10.1056/NEJMoa1608664 10.2188/jea.JE20150011 10.1056/NEJMoa1304501 10.1002/ijc.30824 |
ContentType | Journal Article |
Copyright | 2022 John Wiley & Sons Ltd. 2022 John Wiley & Sons Ltd |
Copyright_xml | – notice: 2022 John Wiley & Sons Ltd. – notice: 2022 John Wiley & Sons Ltd |
DBID | CGR CUY CVF ECM EIF NPM AAYXX CITATION 7T5 7TK H94 K9. 7X8 |
DOI | 10.1111/dom.14614 |
DatabaseName | Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed CrossRef Immunology Abstracts Neurosciences Abstracts AIDS and Cancer Research Abstracts ProQuest Health & Medical Complete (Alumni) MEDLINE - Academic |
DatabaseTitle | MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) CrossRef AIDS and Cancer Research Abstracts ProQuest Health & Medical Complete (Alumni) Immunology Abstracts Neurosciences Abstracts MEDLINE - Academic |
DatabaseTitleList | AIDS and Cancer Research Abstracts MEDLINE - Academic CrossRef MEDLINE |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
EISSN | 1463-1326 |
EndPage | 630 |
ExternalDocumentID | 10_1111_dom_14614 34866302 DOM14614 |
Genre | article Research Support, Non-U.S. Gov't Journal Article |
GrantInformation_xml | – fundername: Cancer Research UK Manchester Centre funderid: C147/A18083; C147/A25254 – fundername: Manchester NIHR Biomedical Research Centre funderid: IS‐BRC‐1215‐20007 – fundername: Cancer Research UK Manchester Centre grantid: C147/A25254 – fundername: Cancer Research UK Manchester Centre grantid: C147/A18083 – fundername: Department of Health – fundername: Manchester NIHR Biomedical Research Centre grantid: IS-BRC-1215-20007 |
GroupedDBID | --- .3N .GA .GJ .Y3 05W 0R~ 10A 1OC 29F 31~ 33P 36B 3SF 4.4 50Y 50Z 51W 51X 52M 52N 52O 52P 52R 52S 52T 52U 52V 52W 52X 53G 5GY 5HH 5LA 5VS 66C 702 7PT 8-0 8-1 8-3 8-4 8-5 8UM 930 A01 A03 AAESR AAEVG AAHHS AAKAS AANLZ AAONW AASGY AAXRX AAZKR ABCQN ABCUV ABEML ABPVW ABQWH ABXGK ACAHQ ACBWZ ACCFJ ACCZN ACGFS ACGOF ACMXC ACPOU ACPRK ACSCC ACXBN ACXQS ADBBV ADBTR ADEOM ADIZJ ADKYN ADMGS ADOZA ADXAS ADZCM ADZMN ADZOD AEEZP AEIGN AEIMD AENEX AEQDE AEUQT AEUYR AFBPY AFEBI AFFPM AFGKR AFPWT AFZJQ AHBTC AHMBA AIACR AITYG AIURR AIWBW AJBDE ALAGY ALMA_UNASSIGNED_HOLDINGS ALUQN AMBMR AMYDB ASPBG ATUGU AVWKF AZBYB AZFZN AZVAB BAFTC BDRZF BFHJK BHBCM BMXJE BROTX BRXPI BY8 C45 CAG COF CS3 D-6 D-7 D-E D-F DCZOG DPXWK DR2 DRFUL DRMAN DRSTM DU5 EBS EJD EMOBN ESX EX3 F00 F01 F04 F5P FEDTE FUBAC G-S G.N GODZA H.X HF~ HGLYW HVGLF HZI HZ~ IHE IX1 J0M K48 KBYEO LATKE LC2 LC3 LEEKS LH4 LITHE LOXES LP6 LP7 LUTES LW6 LYRES MEWTI MK4 MRFUL MRMAN MRSTM MSFUL MSMAN MSSTM MXFUL MXMAN MXSTM N04 N05 N9A NF~ O66 O9- OIG OVD P2W P2X P2Z P4B P4D PQQKQ Q.N Q11 QB0 R.K ROL RX1 SUPJJ TEORI UB1 W8V W99 WBKPD WHWMO WIH WIJ WIK WOHZO WOW WQJ WRC WVDHM WXI WXSBR XG1 YFH ZZTAW ~IA ~KM ~WT CGR CUY CVF ECM EIF NPM AAYXX CITATION 7T5 7TK H94 K9. 7X8 |
ID | FETCH-LOGICAL-c3884-5186e973bfb7ab85325b5d9f951953ad923e38276b9342c5e1a7806bc161c6903 |
IEDL.DBID | DR2 |
ISSN | 1462-8902 |
IngestDate | Fri Aug 16 05:10:12 EDT 2024 Thu Oct 10 17:57:57 EDT 2024 Fri Aug 23 00:47:20 EDT 2024 Sat Sep 28 08:22:17 EDT 2024 Sat Aug 24 00:57:23 EDT 2024 |
IsDoiOpenAccess | false |
IsOpenAccess | true |
IsPeerReviewed | false |
IsScholarly | true |
Issue | 4 |
Keywords | mortality cancer type 2 diabetes obesity BMI |
Language | English |
License | 2022 John Wiley & Sons Ltd. |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c3884-5186e973bfb7ab85325b5d9f951953ad923e38276b9342c5e1a7806bc161c6903 |
Notes | Funding information Darren M. Ashcroft, Matthew Sperrin and Andrew G. Renehan are the Joint senior authors. Cancer Research UK Manchester Centre, Grant/Award Numbers: C147/A18083, C147/A25254; Manchester NIHR Biomedical Research Centre, Grant/Award Number: IS‐BRC‐1215‐20007 Nasra N. Alam and Alison K. Wright are the Joint first authors. ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
ORCID | 0000-0003-4362-9928 0000-0002-8418-8332 |
OpenAccessLink | https://pure.manchester.ac.uk/ws/files/208395782/DOM_DIAMOND1_Complete_manuscript_Revision_V4.docx |
PMID | 34866302 |
PQID | 2637225023 |
PQPubID | 1006516 |
PageCount | 11 |
ParticipantIDs | proquest_miscellaneous_2607310003 proquest_journals_2637225023 crossref_primary_10_1111_dom_14614 pubmed_primary_34866302 wiley_primary_10_1111_dom_14614_DOM14614 |
PublicationCentury | 2000 |
PublicationDate | April 2022 2022-04-00 20220401 |
PublicationDateYYYYMMDD | 2022-04-01 |
PublicationDate_xml | – month: 04 year: 2022 text: April 2022 |
PublicationDecade | 2020 |
PublicationPlace | Oxford, UK |
PublicationPlace_xml | – name: Oxford, UK – name: England – name: Oxford |
PublicationTitle | Diabetes, obesity & metabolism |
PublicationTitleAlternate | Diabetes Obes Metab |
PublicationYear | 2022 |
Publisher | Blackwell Publishing Ltd Wiley Subscription Services, Inc |
Publisher_xml | – name: Blackwell Publishing Ltd – name: Wiley Subscription Services, Inc |
References | 2007; 147 2017; 40 2021; 9 2017; 5 2015; 15 2021; 4 2011 2013; 226 2011; 61 2008; 7 2014; 370 2018; 61 2012; 35 2017; 376 2010; 63 2016; 13 2012; 308 2015; 25 2010; 27 2013; 13 2019; 48 2016; 375 2008; 337 2017; 141 2010; 30 2014; 99 2008; 371 2016; 68 2019; 110 e_1_2_11_10_1 e_1_2_11_30_1 e_1_2_11_13_1 e_1_2_11_12_1 e_1_2_11_11_1 e_1_2_11_7_1 e_1_2_11_29_1 e_1_2_11_6_1 e_1_2_11_28_1 e_1_2_11_5_1 e_1_2_11_27_1 e_1_2_11_4_1 e_1_2_11_26_1 e_1_2_11_3_1 e_1_2_11_2_1 e_1_2_11_21_1 e_1_2_11_20_1 e_1_2_11_25_1 e_1_2_11_24_1 e_1_2_11_9_1 e_1_2_11_8_1 e_1_2_11_22_1 e_1_2_11_18_1 e_1_2_11_17_1 e_1_2_11_16_1 e_1_2_11_15_1 e_1_2_11_19_1 Renehan AG (e_1_2_11_23_1) 2011; 61 Landman GW (e_1_2_11_14_1) 2010; 30 |
References_xml | – volume: 141 start-page: 1170 issue: 6 year: 2017 end-page: 1180 article-title: Type 2 diabetes, adiposity and cancer morbidity and mortality risk taking into account competing risk of noncancer deaths in a prospective cohort setting publication-title: Int J Cancer – year: 2011 – volume: 99 start-page: E642 issue: 4 year: 2014 end-page: E646 article-title: Improved survival among patients with complicated type 2 diabetes in Denmark: a prospective study (2002‐2010) publication-title: J Clin Endocrinol Metab – volume: 61 start-page: 2140 issue: 10 year: 2018 end-page: 2154 article-title: Sex differences in the association between diabetes and cancer: a systematic review and meta‐analysis of 121 cohorts including 20 million individuals and one million events publication-title: Diabetologia – volume: 13 issue: 8 year: 2016 article-title: Duration of adulthood overweight, obesity, and cancer risk in the women's health initiative: a longitudinal study from the United States publication-title: PLoS Med – volume: 63 start-page: 728 issue: 7 year: 2010 end-page: 736 article-title: Unpredictable bias when using the missing indicator method or complete case analysis for missing confounder values: an empirical example publication-title: J Clin Epidemiol – volume: 61 start-page: 783 year: 2011 article-title: Cumulative incidence of metachronous colorectal cancer risk for mismatch repair gene mutation carriers is overestimated publication-title: Gut – volume: 35 start-page: 1835 issue: 9 year: 2012 end-page: 1844 article-title: Diabetes and cause‐specific mortality in a prospective cohort of one million U.S. adults publication-title: Diabetes Care – volume: 13 start-page: 13 year: 2013 article-title: Flexible parametric modelling of cause‐specific hazards to estimate cumulative incidence functions publication-title: BMC Med Res Methodol – volume: 147 start-page: 149 issue: 3 year: 2007 end-page: 155 article-title: Mortality trends in men and women with diabetes, 1971 to 2000 publication-title: Ann Intern Med – volume: 5 issue: 1 year: 2017 article-title: Obesity paradox and mortality in adults with and without incident type 2 diabetes: a matched population‐level cohort study publication-title: BMJ Open Diabetes Res Care – volume: 15 start-page: 484 issue: 8 year: 2015 end-page: 498 article-title: Adiposity and cancer risk: new mechanistic insights from epidemiology publication-title: Nat Rev Cancer – volume: 40 start-page: 338 issue: 3 year: 2017 end-page: 345 article-title: Life expectancy and cause‐specific mortality in type 2 diabetes: a population‐based cohort study quantifying relationships in ethnic subgroups publication-title: Diabetes Care – volume: 4 issue: 3 year: 2021 article-title: Prevalence of missing data in the national cancer database and association with overall survival publication-title: JAMA Netw Open – volume: 27 start-page: 203 issue: 2 year: 2010 end-page: 209 article-title: A method of identifying and correcting miscoding, misclassification and misdiagnosis in diabetes: a pilot and validation study of routinely collected data publication-title: Diabet Med – volume: 68 start-page: 1598 issue: 11 year: 2016 end-page: 1606 article-title: Smoking‐related mortality in patients with early rheumatoid arthritis: a retrospective cohort study using the clinical practice research datalink publication-title: Arthritis Care Res – volume: 308 start-page: 581 issue: 6 year: 2012 end-page: 590 article-title: Association of weight status with mortality in adults with incident diabetes publication-title: JAMA – volume: 376 start-page: 1407 issue: 15 year: 2017 end-page: 1418 article-title: Mortality and cardiovascular disease in type 1 and type 2 diabetes publication-title: N Engl J Med – volume: 370 start-page: 233 issue: 3 year: 2014 end-page: 244 article-title: Body‐mass index and mortality among adults with incident type 2 diabetes publication-title: N Engl J Med – volume: 375 start-page: 794 issue: 8 year: 2016 article-title: Body fatness and cancer‐‐Viewpoint of the IARC Working Group publication-title: N Engl J Med – volume: 48 start-page: 527 issue: 2 year: 2019 end-page: 537 article-title: Metformin use and risk of cancer in patients with type 2 diabetes: a cohort study of primary care records using inverse probability weighting of marginal structural models publication-title: Int J Epidemiol – volume: 25 start-page: 553 issue: 8 year: 2015 end-page: 558 article-title: Association of body mass index and mortality in Japanese diabetic men and women based on self‐reports: the Japan Collaborative Cohort (JACC) Study publication-title: J Epidemiol – volume: 337 year: 2008 article-title: Secular decline in mortality from coronary heart disease in adults with diabetes mellitus: cohort study publication-title: BMJ (Clinical Research Ed) – volume: 110 start-page: 63 year: 2019 end-page: 73 article-title: The proportion of missing data should not be used to guide decisions on multiple imputation publication-title: J Clin Epidemiol – volume: 30 start-page: 681 issue: 2 year: 2010 end-page: 682 article-title: The relationship between obesity and cancer mortality in type 2 diabetes: a ten‐year follow‐up study (ZODIAC‐21) publication-title: Anticancer Res – volume: 226 start-page: 186 issue: 1 year: 2013 end-page: 192 article-title: Obesity paradox: differential effects on cancer and noncancer mortality in patients with type 2 diabetes mellitus publication-title: Atherosclerosis – volume: 9 start-page: 165 issue: 3 year: 2021 end-page: 173 article-title: Trends in predominant causes of death in individuals with and without diabetes in England from 2001 to 2018: an epidemiological analysis of linked primary care records publication-title: Lancet Diabetes Endocrinol – volume: 371 start-page: 569 issue: 9612 year: 2008 end-page: 578 article-title: Body‐mass index and incidence of cancer: a systematic review and meta‐analysis of prospective observational studies publication-title: Lancet (London, England) – volume: 7 start-page: 32 year: 2008 article-title: Improved survival in both men and women with diabetes between 1980 and 2004–a cohort study in Sweden publication-title: Cardiovasc Diabetol – ident: e_1_2_11_29_1 doi: 10.1371/journal.pmed.1002081 – ident: e_1_2_11_19_1 doi: 10.1016/j.jclinepi.2019.02.016 – ident: e_1_2_11_10_1 doi: 10.1007/s00125-018-4664-5 – ident: e_1_2_11_28_1 doi: 10.1001/jama.2012.9282 – volume: 61 start-page: 783 year: 2011 ident: e_1_2_11_23_1 article-title: Cumulative incidence of metachronous colorectal cancer risk for mismatch repair gene mutation carriers is overestimated publication-title: Gut contributor: fullname: Renehan AG – ident: e_1_2_11_3_1 doi: 10.1136/bmj.39582.447998.BE – ident: e_1_2_11_27_1 doi: 10.1136/bmjdrc-2016-000369 – ident: e_1_2_11_2_1 doi: 10.7326/0003-4819-147-3-200708070-00167 – ident: e_1_2_11_30_1 doi: 10.1093/ije/dyz005 – ident: e_1_2_11_9_1 doi: 10.1016/S2213-8587(20)30431-9 – volume: 30 start-page: 681 issue: 2 year: 2010 ident: e_1_2_11_14_1 article-title: The relationship between obesity and cancer mortality in type 2 diabetes: a ten‐year follow‐up study (ZODIAC‐21) publication-title: Anticancer Res contributor: fullname: Landman GW – ident: e_1_2_11_6_1 doi: 10.1210/jc.2013-3210 – ident: e_1_2_11_15_1 doi: 10.1016/j.atherosclerosis.2012.09.004 – ident: e_1_2_11_11_1 doi: 10.1056/NEJMsr1606602 – ident: e_1_2_11_4_1 doi: 10.1186/1475-2840-7-32 – ident: e_1_2_11_7_1 doi: 10.2337/dc12-0002 – ident: e_1_2_11_18_1 doi: 10.1111/j.1464-5491.2009.02917.x – ident: e_1_2_11_20_1 – ident: e_1_2_11_21_1 doi: 10.1002/acr.22882 – ident: e_1_2_11_22_1 doi: 10.1186/1471-2288-13-13 – ident: e_1_2_11_5_1 doi: 10.2337/dc16-1616 – ident: e_1_2_11_12_1 doi: 10.1016/S0140-6736(08)60269-X – ident: e_1_2_11_25_1 doi: 10.1001/jamanetworkopen.2021.1793 – ident: e_1_2_11_26_1 doi: 10.1016/j.jclinepi.2009.08.028 – ident: e_1_2_11_24_1 doi: 10.1038/nrc3967 – ident: e_1_2_11_8_1 doi: 10.1056/NEJMoa1608664 – ident: e_1_2_11_13_1 doi: 10.2188/jea.JE20150011 – ident: e_1_2_11_17_1 doi: 10.1056/NEJMoa1304501 – ident: e_1_2_11_16_1 doi: 10.1002/ijc.30824 |
SSID | ssj0004387 |
Score | 2.410283 |
Snippet | Aims
We evaluated the relationship between body mass index (BMI) and cancer mortality in incident type 2 diabetes.
Methods
We used the Clinical Practice... We evaluated the relationship between body mass index (BMI) and cancer mortality in incident type 2 diabetes. We used the Clinical Practice Research Datalink... Abstract Aims We evaluated the relationship between body mass index (BMI) and cancer mortality in incident type 2 diabetes. Methods We used the Clinical... AimsWe evaluated the relationship between body mass index (BMI) and cancer mortality in incident type 2 diabetes.MethodsWe used the Clinical Practice Research... AIMSWe evaluated the relationship between body mass index (BMI) and cancer mortality in incident type 2 diabetes. METHODSWe used the Clinical Practice Research... |
SourceID | proquest crossref pubmed wiley |
SourceType | Aggregation Database Index Database Publisher |
StartPage | 620 |
SubjectTerms | Adult Aged Aged, 80 and over BMI Body Mass Index Cancer Cardiovascular diseases Cardiovascular Diseases - complications Diabetes Diabetes mellitus (non-insulin dependent) Diabetes Mellitus, Type 2 - complications Diabetes Mellitus, Type 2 - epidemiology Endometrium Female Humans Male Middle Aged Mortality Neoplasms - complications Neoplasms - epidemiology Obesity Obesity - complications Obesity - epidemiology Patients Population studies Population-based studies Risk Factors Smoking type 2 diabetes |
Title | Body mass index and cancer mortality in patients with incident type 2 diabetes: A population‐based study of adults in England |
URI | https://onlinelibrary.wiley.com/doi/abs/10.1111%2Fdom.14614 https://www.ncbi.nlm.nih.gov/pubmed/34866302 https://www.proquest.com/docview/2637225023 https://search.proquest.com/docview/2607310003 |
Volume | 24 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3NTtwwEB6tOFS9FEpL2ULRgHrgEpTYTpzQ07YUISRaqQKJQ6UodpwL2gSxu4dygUfgGXkSZpyfFqpKFbdInsiJPeP5PB5_A_CROdBEUkSB49IBSuowMK7UgTW0wZVlxqxQnG3xLTk6U8fn8fkIPvV3YVp-iCHgxpbh12s28MLM_jDyspmymfsi1pHUnM518OM3dZSSvjgeSZDFZ5zFs9Jn8QxvPvZFfwHMx3jVO5zDZfjZf2qbZ3Kxt5ibPXv9hMXxmf-yAq86IIqTVnNew8jVq_DipDtqfwM3n5vyF04JW6NnVMSiLtGyjlzh1GN2wu_UhB0z6ww5pIscuue7v8ixXRTYx3b3cYKXQ7Gw-9s7dp8lenZbbCr0PCDcFXZlRd7C2eHX0y9HQVetIbAyTVUQR2niMi1NZXRhCAWI2MRlVmXMXyOLkpCkk6nQicmkEjZ2UaHTMDGWMKelPbpcg6W6qd06YGRTGRqrqzgzShtlYqWFU2mSkEcP02oMO_285ZctKUfeb2ZoKHM_lGPY7Gc07-xylotEalrBCKiMYXtoJoviY5Kids2CZWjZ42MPknnXasLQi-SPkKEYw66fz393nx98P_EP7_9fdANeCr5d4RODNmFpfrVwHwjzzM2WV-4HpQv7tw |
link.rule.ids | 315,783,787,1378,27938,27939,46308,46732 |
linkProvider | Wiley-Blackwell |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1PT9VAEJ8QSNQLICo8RB2MBy4lfbvbbmu8oEAeysPEQMLFNN3t9kJeS-C9A17kI_AZ_STObP8gGhLirclOs-3uzM5vZ2d_A_COOdBEnA8Dx6UDlNRhYFyhA2togyuLlFmhONviKB6dqM-n0ekcfOjuwjT8EH3AjS3Dr9ds4ByQ_sPKi3rCds5VrBfI3CXXL9j9dksepaQvj0ciZPMp5_Esd3k8_at3vdE_EPMuYvUuZ38Jvncf22SanG3Ppmbb_viLx_F__2YZFlssijuN8jyFOVetwKNxe9r-DH5-rIsrnBC8Rk-qiHlVoGU1ucCJh-0E4akJW3LWS-SoLnL0nq__Iod3UWAX3n2PO3je1wv7dX3DHrRAT3CLdYmeCoS7wrayyHM42d87_jQK2oINgZVJooJomMQu1dKURueGgICITFSkZcoUNjIvCEw6mQgdm1QqYSM3zHUSxsYS7LS0TZcvYL6qK7cGOLSJDI3VZZQapY0ykdLCqSSOyamHSTmAt93EZecNL0fW7WdoKDM_lAPY6KY0a03zMhOx1LSIEVYZwGbfTEbFJyV55eoZy9DKxycfJLPaqELfi-SPkKEYwJaf0Pu7z3a_jv3D-sNF38Dj0fH4MDs8OPryEp4Ivmzh84Q2YH56MXOvCAJNzWuv6b8BVrf_0Q |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9QwEB5VRaq4QHl2ocCAOHBJlbUdO4FTYVmVRwtCVOoBKYofuaBNVu3uAS7wE_iN_BJmnAcUhIS4RfJETuwZz-fx-BuAh8yBJnQ1TQKXDlDSpIkN3iTO0gZX-oJZoTjb4kgfHKuXJ9nJBjwZ7sJ0_BBjwI0tI67XbOBLX_9i5L5dsJlzEesLSsuU87lm735yRykZq-ORCJl8wWk820Maz_jqeWf0B8I8D1ijx5lfhg_Dt3aJJh_31iu75z7_RuP4nz-zDZd6JIr7nepcgY3QXIWtw_6s_Rp8edr6T7ggcI2RUhGrxqNjJTnFRQTtBOCpCXtq1jPkmC5y7J4v_yIHd1HgENx9jPu4HKuFff_6jf2nx0hvi22NkQiEu8K-rsh1OJ4_f__sIOnLNSRO5rlKsmmuQ2Gkra2pLMEAkdnMF3XBBDay8gQlg8yF0baQSrgsTCuTp9o6Ap2ONunyBmw2bRN2AKcul6l1ps4Kq4xVNlNGBJVrTS49zesJPBjmrVx2rBzlsJuhoSzjUE5gd5jRsjfMs1JoaWgJI6QygftjM5kUn5NUTWjXLEPrHp97kMzNThPGXiR_hEzFBB7F-fx79-XszWF8uPXvovdg6-1sXr5-cfTqNlwUfNMiJgntwubqdB3uEP5Z2btRz38AW1_-gA |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Body+mass+index+and+cancer+mortality+in+patients+with+incident+type+2+diabetes%3A+A+population-based+study+of+adults+in+England&rft.jtitle=Diabetes%2C+obesity+%26+metabolism&rft.au=Alam%2C+Nasra+N&rft.au=Wright%2C+Alison+K&rft.au=Rutter%2C+Martin+K&rft.au=Buchan%2C+Iain&rft.date=2022-04-01&rft.eissn=1463-1326&rft.volume=24&rft.issue=4&rft.spage=620&rft_id=info:doi/10.1111%2Fdom.14614&rft_id=info%3Apmid%2F34866302&rft.externalDocID=34866302 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1462-8902&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1462-8902&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1462-8902&client=summon |